作者: Manon Haché , André Y. Denault , Sylvain Bélisle , Pierre Couture , Denis Babin
DOI: 10.1007/BF03017361
关键词: Medicine 、 Hypoxemia 、 Anesthesia 、 Hypoxia (medical) 、 Pulmonary hypertension 、 Respiratory disease 、 Inhalation 、 Intensive care unit 、 Anesthesiology 、 Intensive care
摘要: Purpose There is a growing interest in the intraoperative and intensive care use of inhaled epoprostenol (PGI2) for treatment pulmonary hypertension (PHT) hypoxia cardiac or noncardiac origin. We report our experience with this form therapy.